Schrödinger (NASDAQ:SDGR) Lowered to “Sell” at Zacks Investment Research

Schrödinger (NASDAQ:SDGRGet Rating) was downgraded by Zacks Investment Research from a “hold” rating to a “sell” rating in a research report issued on Tuesday, Zacks.com reports.

According to Zacks, “Schrödinger Inc. provides computational platforms to accelerate drug discovery and materials design deployed by biopharmaceutical and industrial companies, academic institutions and government laboratories. Schrödinger Inc. is based in NEW YORK. “

Several other research firms also recently weighed in on SDGR. Citigroup initiated coverage on Schrödinger in a research report on Monday, February 28th. They set a “buy” rating and a $55.00 target price on the stock. Piper Sandler decreased their price target on Schrödinger from $87.00 to $84.00 in a report on Friday, February 25th. One analyst has rated the stock with a sell rating, two have issued a hold rating and four have assigned a buy rating to the company. According to MarketBeat, the stock currently has an average rating of “Hold” and an average price target of $70.14.

SDGR traded up $0.47 during trading on Tuesday, hitting $23.83. 1,688 shares of the company’s stock traded hands, compared to its average volume of 833,311. The company’s 50 day simple moving average is $30.73 and its two-hundred day simple moving average is $34.50. Schrödinger has a 12-month low of $22.39 and a 12-month high of $79.75. The stock has a market capitalization of $1.69 billion, a price-to-earnings ratio of -12.61 and a beta of 1.21.

Schrödinger (NASDAQ:SDGRGet Rating) last issued its earnings results on Wednesday, May 4th. The company reported ($0.48) EPS for the quarter, beating the consensus estimate of ($0.52) by $0.04. Schrödinger had a negative return on equity of 23.72% and a negative net margin of 87.27%. The business had revenue of $48.60 million for the quarter, compared to the consensus estimate of $34.57 million. Schrödinger’s quarterly revenue was up 51.4% on a year-over-year basis. As a group, sell-side analysts anticipate that Schrödinger will post -2.02 earnings per share for the current fiscal year.

A number of large investors have recently modified their holdings of the stock. Principal Financial Group Inc. raised its stake in Schrödinger by 6.8% in the first quarter. Principal Financial Group Inc. now owns 8,229 shares of the company’s stock worth $281,000 after buying an additional 523 shares in the last quarter. Swiss National Bank raised its stake in Schrödinger by 7.7% in the first quarter. Swiss National Bank now owns 116,700 shares of the company’s stock worth $3,982,000 after buying an additional 8,300 shares in the last quarter. Teacher Retirement System of Texas raised its stake in Schrödinger by 6.2% in the first quarter. Teacher Retirement System of Texas now owns 10,212 shares of the company’s stock worth $348,000 after buying an additional 595 shares in the last quarter. Capital Advisors Ltd. LLC acquired a new position in shares of Schrödinger during the first quarter worth $68,000. Finally, Baillie Gifford & Co. increased its position in shares of Schrödinger by 521,739.3% during the first quarter. Baillie Gifford & Co. now owns 1,262,851 shares of the company’s stock worth $43,088,000 after purchasing an additional 1,262,609 shares in the last quarter. 62.31% of the stock is owned by institutional investors.

Schrödinger Company Profile (Get Rating)

Schrödinger, Inc, together with its subsidiaries, provides physics-based software platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on selling its software for drug discovery in the life sciences industry, as well as to customers in materials science industries.

Featured Articles

Get a free copy of the Zacks research report on Schrödinger (SDGR)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Analyst Recommendations for Schrödinger (NASDAQ:SDGR)

Receive News & Ratings for Schrödinger Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Schrödinger and related companies with MarketBeat.com's FREE daily email newsletter.